FDA Clears PixCell Medical’s HemoScreen™ Point of Care CBC for Direct Capillary Sampling Significantly Enhancing Ease-of-Use & Testing Throughput

YOKNEAM ILLIT, Israel, Aug. 23, 2023 /PRNewswire/ — PixCell Medical, an innovator of rapid hematology testing solutions at the point of care (POC), is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for direct capillary sampling with the…

Click here to view original post